Correlation Between Bright Minds and Candel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bright Minds and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bright Minds and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bright Minds Biosciences and Candel Therapeutics, you can compare the effects of market volatilities on Bright Minds and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bright Minds with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bright Minds and Candel Therapeutics.

Diversification Opportunities for Bright Minds and Candel Therapeutics

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Bright and Candel is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Bright Minds Biosciences and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Bright Minds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bright Minds Biosciences are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Bright Minds i.e., Bright Minds and Candel Therapeutics go up and down completely randomly.

Pair Corralation between Bright Minds and Candel Therapeutics

Given the investment horizon of 90 days Bright Minds Biosciences is expected to generate 0.79 times more return on investment than Candel Therapeutics. However, Bright Minds Biosciences is 1.27 times less risky than Candel Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Candel Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  3,686  in Bright Minds Biosciences on December 28, 2024 and sell it today you would lose (69.00) from holding Bright Minds Biosciences or give up 1.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bright Minds Biosciences  vs.  Candel Therapeutics

 Performance 
       Timeline  
Bright Minds Biosciences 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Bright Minds is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Candel Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Candel Therapeutics is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Bright Minds and Candel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bright Minds and Candel Therapeutics

The main advantage of trading using opposite Bright Minds and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bright Minds position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.
The idea behind Bright Minds Biosciences and Candel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities